secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001193125-26-015524
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics issues $2.5M unsecured promissory note with 20% OID to Funicular Funds
--------------------------------------------------------------------------------

- Issued $2.5M principal unsecured promissory note sold for $2M (20% original issue discount) to Funicular Funds, LP.
- Note matures on earlier of next $10M+ equity closing or June 30, 2026; no periodic interest.
- Proceeds from private placement provide working capital; note exempt under Section 4(a)(2) and Rule 506.
- Agreement includes customary representations, warranties, and covenants; note is unsecured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526015524/0001193125-26-015524-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312526015524/d80335d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-015524

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer